Arthritis & Rheumatism

Arthritis & Rheumatism

Positive outcome no more likely in industry-funded trials

(HealthDay) -- Industry-sponsored clinical trials of rheumatoid arthritis drugs are no more likely to report positive outcomes than trials funded by other means, and in many cases use better methodology, according to research ...

Arthritis & Rheumatism

Rheumatoid arthritis drug not linked to specific birth defects

(HealthDay) -- The rheumatoid arthritis drug leflunomide is not a major cause of birth defects in women who inadvertently become pregnant while taking the drug, although pregnancy should be avoided, according to a study in ...

Arthritis & Rheumatism

Long-term rituximab safe for patients with wegener's

(HealthDay) -- Repeated and prolonged use of rituximab for B-cell depletion to treat relapses or maintain remission is safe and effective in patients with refractory granulomatosis with polyangiitis (GPA; Wegener's), a primary ...

Arthritis & Rheumatism

Belimumab deemed safe for long-term lupus treatment

(HealthDay) -- For patients with systemic lupus erythematosus (SLE), long-term belimumab therapy combined with standard therapy is well tolerated, according to a study published online June 5 in Arthritis & Rheumatism.

page 5 from 6